Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Adocia    ADOC   FR0011184241

ADOCIA (ADOC)

Delayed Quote. Delayed  - 04/28 05:35:12 pm
19.23 EUR   -0.31%
04/18 ADOCIA : announces first quarter 2017 financial results
04/13ADOCIA SAS : quaterly sales release
03/02ADOCIA SAS : annual earnings release
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Adocia
Operates as a clinical-stage biotechnology company

Adocia SA operates as a clinical-stage biotechnology company, which engages in the development of medicines from already approved therapeutic agents.

Its product pipeline includes BioChaperone PDGF, which is in Phase III clinical trials for the treatment of diabetic foot ulcer; BioChaperone insulin that is in Phase I/II clinical trials, as well as in pre-clinical staged for the treatment of diabetes; and Driveln, which is in preclinical stage for the treatment of oncology.

The company was founded by Gérard Soula, OLivier Soula, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.



Number of employees : 125 persons.
Sales per Businesses
20152016Delta
EUR (in Million)%EUR (in Million)%
Regenerating Medicine36.94100%22.49100% -39.12%
Sales per Regions
20152016Delta
EUR (in Million)%EUR (in Million)%
France36.94100%22.49100% -39.12%
Managers
NameAgeSinceTitle
Gérard Soula PhD, MBA692005Chairman, President & Chief Executive Officer
Valérie Danaguezian-2006Chief Financial Officer & Administrative Director
Olivier Soula PhD, MBA482005Director, Deputy General Manager, Director-R&D
Olivier Martinez PhD, MBA47-Director
Laurent Arthaud55-Director
Dominique Takizawa602011Independent Director
Ekaterina Smirnyagina, PhD502013Independent Director
Rémi Soula PhD, MBA-2005Director-Business Development
David Duracher, PhD--Director-Pharmaceutical Development
Géraldine Favre-Soula--Director-Human Resources Development Department
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 6,846,363 5,249,424 76.7% 760 0.0% 76.7%
Shareholders
NameEquities%
Gérard Soula PhD, MBA 898,463 13.1%
BPIFrance Investissement SAS 738,639 10.8%
La Société Hospitalière d'Assurances Mutuelles SA 320,000 4.66%
Rémi Soula PhD, MBA 300,490 4.38%
Olivier Soula PhD, MBA 297,490 4.34%
Norges Bank Investment Management 82,675 1.21%
ACG Management SAS 67,439 0.98%
Aviva Investors France SA 59,601 0.87%
CM-CIC Asset Management SA 50,080 0.73%
BlackRock Fund Advisors 44,296 0.65%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Bio Therapeutic Drugs
1st jan.Capitalization (M$)
ADOCIA-68.38%144
AMGEN, INC.11.70%120 105
CELGENE CORPORATION7.17%96 861
GILEAD SCIENCES, INC.-4.27%89 611
REGENERON PHARMACEUTIC..5.83%41 293
VERTEX PHARMACEUTICALS..60.58%29 390
ACTELION LTD24.13%28 742
GENMAB A/S16.54%12 137
TESARO INC9.75%7 941
EXELIXIS, INC.50.23%6 548
BIOVERATIV INC0.00%6 272
HUALAN BIOLOGICAL ENGI..--.--%4 942
NEUROCRINE BIOSCIENCES..37.98%4 674
KITE PHARMA INC83.05%4 501
TONGHUA DONGBAO PHARMA..-1.00%4 460
BLUEBIRD BIO INC44.17%3 642
BIOCON LTD18.54%3 434
PEPTIDREAM INC9.70%3 427
CHINA BIOLOGIC PRODUCT..9.75%3 208
INTERCEPT PHARMACEUTIC..3.41%2 790
ULTRAGENYX PHARMACEUTI..-8.42%2 687
Sector Bio Therapeutic Drugs
Adocia : Connections
BPIFrance Investissement SAS
Lyon Place Financière & Tertiaire
Institut Mérieux SA
Alizé Pharma SAS
Platine Pharma Services SAS
Elsalys Biotech SAS
iSTAR Medical SA
Capricorn Venture Partners NV
Lyon Pôle Bourse
Company contact information
115 avenue Lacassagne
FR-69003 Lyon
France

Phone : +33 (0)4 72 610 610
Fax : +33 (0)4 72 36 39 67
Internet : http://www.adocia.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment B
- CAC All Shares / CAC All-Tradable, CAC Mid Small, CAC PME, CAC Small, EnterNext© PEA-PME 150, Next 150, Next Biotech, PEA, PEA-PME, Tech 40
Stock Exchange Codes
- ISIN Code :  FR0011184241
- Bloomberg Code :  ADOC:FP
- Reuters Code :  ADOC.PA
- Datastream Code :  
© 2017 People , Fundamentals and Ownership    © 2017 Cofisem